FDA Inspection 1116523 — ReproTech, Ltd.
The FDA completed an inspection of ReproTech, Ltd. on January 23, 2020 in Saint Paul, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 23, 2020
- Fiscal Year
- 2020
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Saint Paul, MN (United States)